Linking cytochrome P450 enzymes from Mycobacterium tuberculosis to their cognate ferredoxin partners
- PMID: 30136203
- PMCID: PMC6208970
- DOI: 10.1007/s00253-018-9299-4
Linking cytochrome P450 enzymes from Mycobacterium tuberculosis to their cognate ferredoxin partners
Abstract
Mycobacterium tuberculosis (Mtb) codes for 20 cytochrome P450 enzymes (CYPs), considered potential drug-targets due to their essential roles in bacterial viability and host infection. Catalytic activity of mycobacterial CYPs is dependent on electron transfer from a NAD (P)H-ferredoxin-reductase (FNR) and a ferredoxin (Fd). Two FNRs (FdrA and FprA) and five ferredoxins (Fdx, FdxA, FdxC, FdxD, and Rv1786) have been found in the Mtb genome. However, as of yet, the cognate redox partnerships have not been fully established. This is confounded by the fact that heterologous redox partners are routinely used to reconstitute Mtb CYP metabolism. To this end, this study aimed to biochemically characterize and identify cognate redox partnerships for Mtb CYPs. Interestingly, all combinations of FNRs and ferredoxins were active in the reduction of oxidized cytochrome c, but steady-state kinetic assays revealed FdxD as the most efficient redox partner for FdrA, whereas Fdx coupled preferably with FprA. CYP121A1, CYP124A1, CYP125A1, and CYP142A1 metabolism with the cognate redox partners was reconstituted in vitro showing an unanticipated selectivity in the requirement for electron transfer partnership, which did not necessarily correlate with proximity in the genome. This is the first description of microbial P450 metabolism in which multiple ferredoxins are functionally linked to multiple CYPs.
Keywords: Cytochrome P450; Ferredoxin; Mycobacterium tuberculosis; NAD (P) H ferredoxin reductase; Redox partners.
Conflict of interest statement
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Figures
Similar articles
-
Recombinant expression and biochemical characterization of Mycobacterium tuberculosis 3Fe-4S ferredoxin Rv1786.Appl Microbiol Biotechnol. 2017 Oct;101(19):7201-7212. doi: 10.1007/s00253-017-8454-7. Epub 2017 Aug 15. Appl Microbiol Biotechnol. 2017. PMID: 28812125
-
Function, essentiality, and expression of cytochrome P450 enzymes and their cognate redox partners in Mycobacterium tuberculosis: are they drug targets?Appl Microbiol Biotechnol. 2019 May;103(9):3597-3614. doi: 10.1007/s00253-019-09697-z. Epub 2019 Feb 27. Appl Microbiol Biotechnol. 2019. PMID: 30810776 Free PMC article. Review.
-
Kinetic, spectroscopic and thermodynamic characterization of the Mycobacterium tuberculosis adrenodoxin reductase homologue FprA.Biochem J. 2003 Jun 1;372(Pt 2):317-27. doi: 10.1042/BJ20021692. Biochem J. 2003. PMID: 12614197 Free PMC article.
-
Biophysical characterization of the sterol demethylase P450 from Mycobacterium tuberculosis, its cognate ferredoxin, and their interactions.Biochemistry. 2006 Jul 11;45(27):8427-43. doi: 10.1021/bi0601609. Biochemistry. 2006. PMID: 16819841
-
Redox Partners: Function Modulators of Bacterial P450 Enzymes.Trends Microbiol. 2020 Jun;28(6):445-454. doi: 10.1016/j.tim.2020.02.012. Epub 2020 Mar 18. Trends Microbiol. 2020. PMID: 32396826 Review.
Cited by
-
Structural insights into 3Fe-4S ferredoxins diversity in M. tuberculosis highlighted by a first redox complex with P450.Front Mol Biosci. 2023 Jan 9;9:1100032. doi: 10.3389/fmolb.2022.1100032. eCollection 2022. Front Mol Biosci. 2023. PMID: 36699703 Free PMC article.
-
Contrasting Health Effects of Bacteroidetes and Firmicutes Lies in Their Genomes: Analysis of P450s, Ferredoxins, and Secondary Metabolite Clusters.Int J Mol Sci. 2022 May 2;23(9):5057. doi: 10.3390/ijms23095057. Int J Mol Sci. 2022. PMID: 35563448 Free PMC article.
-
Diversification of Ferredoxins across Living Organisms.Curr Issues Mol Biol. 2021 Sep 30;43(3):1374-1390. doi: 10.3390/cimb43030098. Curr Issues Mol Biol. 2021. PMID: 34698119 Free PMC article.
-
Comparative Genomics of Mycobacterium avium Subspecies Paratuberculosis Sheep Strains.Front Vet Sci. 2021 Feb 15;8:637637. doi: 10.3389/fvets.2021.637637. eCollection 2021. Front Vet Sci. 2021. PMID: 33659287 Free PMC article.
-
An overview of the factors playing a role in cytochrome P450 monooxygenase and ferredoxin interactions.Biophys Rev. 2020 Oct;12(5):1217-1222. doi: 10.1007/s12551-020-00749-7. Epub 2020 Sep 3. Biophys Rev. 2020. PMID: 32885385 Free PMC article. Review.
References
-
- Belin P, Le Du MH, Fielding A, Lequin O, Jacquet M, Charbonnier JB, Lecoq A, Thai R, Courçon M, Masson C, Dugave C, Genet R, Perdonet JL, Gondry M. Identification and structural basis of the reaction catalyzed by CYP121, an essential cytochrome P450 in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 2009;106(18):7426–7431. doi: 10.1073/pnas.0812191106. - DOI - PMC - PubMed
-
- Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE, 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Dev-Lin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998;393(6685):537–544. doi: 10.1038/31159. - DOI - PubMed
-
- Damsten MC, van Vugt-Lussenburg BM, Zeldenthuis T, de Vlieger JSB, Commandeur JNM, Vermeulen NPE. Application of drug metabolising mutants of cytochrome P450 BM3 (CYP102A1) as biocatalysts for the generation of reactive metabolites. Chem Biol Interact. 2008;171(1):96–107. doi: 10.1016/j.cbi.2007.09.007. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
